Connection

Kim Payne to Animals

Back to Details
This is a "connection" page, showing publications Kim Payne has written about Animals.
Kim Payne
Connection Strength
0.489
Animals
  1. Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line. J Vis Exp. 2017 05 10; (123).
    View in: PubMed
    Score: 0.042
  2. TSLP or IL-7 provide an IL-7Ra signal that is critical for human B lymphopoiesis. Eur J Immunol. 2016 09; 46(9):2155-61.
    View in: PubMed
    Score: 0.039
  3. Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia. J Investig Med. 2016 Mar; 64(3):740-4.
    View in: PubMed
    Score: 0.038
  4. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis. Haematologica. 2016 Apr; 101(4):417-26.
    View in: PubMed
    Score: 0.038
  5. Differences in mouse and human nonmemory B cell pools. J Immunol. 2014 May 15; 192(10):4610-9.
    View in: PubMed
    Score: 0.034
  6. G0S2--a new player in leukemia. Leuk Res. 2014 Feb; 38(2):147-8.
    View in: PubMed
    Score: 0.033
  7. Residency and activation of myeloid cells during remodeling of the prepartum murine cervix. Biol Reprod. 2012 Nov; 87(5):106.
    View in: PubMed
    Score: 0.031
  8. Tumor suppression in T cell leukemia--the role of Ikaros. Leuk Res. 2010 Apr; 34(4):416-7.
    View in: PubMed
    Score: 0.025
  9. IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow. J Immunol. 2009 Apr 01; 182(7):4255-66.
    View in: PubMed
    Score: 0.024
  10. Immune-cell lineage commitment: translation from mice to humans. Immunity. 2007 Jun; 26(6):674-7.
    View in: PubMed
    Score: 0.021
  11. Ikaros isoform x is selectively expressed in myeloid differentiation. J Immunol. 2003 Mar 15; 170(6):3091-8.
    View in: PubMed
    Score: 0.016
  12. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia. Blood. 2020 09 24; 136(13):1520-1534.
    View in: PubMed
    Score: 0.013
  13. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia. Int J Mol Sci. 2020 Mar 22; 21(6).
    View in: PubMed
    Score: 0.013
  14. Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity. Leukemia. 2019 11; 33(11):2720-2731.
    View in: PubMed
    Score: 0.012
  15. Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Exp Hematol. 2017 06; 50:1-12.
    View in: PubMed
    Score: 0.010
  16. Cutting Edge: Hematopoietic Stem Cell Expansion and Common Lymphoid Progenitor Depletion Require Hematopoietic-Derived, Cell-Autonomous TLR4 in a Model of Chronic Endotoxin. J Immunol. 2015 Sep 15; 195(6):2524-8.
    View in: PubMed
    Score: 0.009
  17. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood. 2015 Oct 08; 126(15):1813-22.
    View in: PubMed
    Score: 0.009
  18. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia. Pediatr Blood Cancer. 2014 Dec; 61(12):2230-5.
    View in: PubMed
    Score: 0.009
  19. Human papillomavirus type 16 E6* induces oxidative stress and DNA damage. J Virol. 2014 Jun; 88(12):6751-61.
    View in: PubMed
    Score: 0.008
  20. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One. 2013; 8(5):e64496.
    View in: PubMed
    Score: 0.008
  21. Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells. PLoS One. 2013; 8(4):e59908.
    View in: PubMed
    Score: 0.008
  22. Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor. Cell Res. 2013 May; 23(5):658-72.
    View in: PubMed
    Score: 0.008
  23. Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis. Peptides. 2011 Oct; 32(10):2058-66.
    View in: PubMed
    Score: 0.007
  24. Ikaros, CK2 kinase, and the road to leukemia. Mol Cell Biochem. 2011 Oct; 356(1-2):201-7.
    View in: PubMed
    Score: 0.007
  25. Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res. 2011 Jan 25; 1370:64-79.
    View in: PubMed
    Score: 0.007
  26. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem. 2009 May 15; 284(20):13869-13880.
    View in: PubMed
    Score: 0.006
  27. Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem. 2008 Mar 28; 283(13):8291-300.
    View in: PubMed
    Score: 0.005
  28. Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem. 2007 Jan 26; 282(4):2538-47.
    View in: PubMed
    Score: 0.005
  29. SCL expression at critical points in human hematopoietic lineage commitment. Stem Cells. 2005 Jun-Jul; 23(6):852-60.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.